Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Xefo introduced by CeNeS in U.K.

Sep. 7, 2001

New series of N-acylpeptide hydrolase inhibitors useful in Rx of CNS diseases

Sep. 6, 2001

Preparation, activity and use of new delta opioid receptor ligands reported by Meiji Seika

Sep. 6, 2001

FDA approves Topamax for treatment of Lennox-Gastaut syndrome

Sep. 6, 2001

Potential analgesic agents claimed by AstraZeneca in recent patents

Sep. 5, 2001

iGluR5-selective glutamate receptor antagonists useful for migraine Rx

Sep. 5, 2001

SBIR grant received by Acorda for spinal cord injury regeneration research

Sep. 5, 2001

Pyrazolopyridine adenosine A1 antagonist selected for further development at Fujisawa

Sep. 4, 2001

Cephalon reports changes in Gabitril product name

Sep. 4, 2001

Neuromuscular blockade reversed by cyclodextrin-based compounds

Sep. 3, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...